摘要
肠促胰岛素是一类在食物刺激下由肠道L细胞分泌并能促使胰岛素分泌的激素,其主要包括胰高血糖素样肽-1(GLP-1)受体激动剂类似物和二肽基肽酶-4(DPP-4)抑制剂。药代动力学/药效学(PK/PD)结合模型可以为肠促胰岛素相关药物的治疗和临床研究提供有力的工具,同时,基于机制的模型可以更好地预测给药后的生理学特点和不同给药方案的治疗结果,有利于该类药物新药研发及给药方案的调整。本文主要针对GLP-1受体激动剂类似物和DPP-4抑制剂代表药物基于其作用机制的PK/PD模型进行综述。
Incretin is a hormone released from the L -cells in the gut wall under the stimulation of food and can promote the insulin secretion.The related agents used in the clinic mainly include two types , the gluca-gon-like peptide-1 （ GLP-1 ） receptor agonists and dipeptidyl pepti-dase -4 （ DPP -4 ） inhibitors.Pharmacokinetic/pharmacodynamic （ PK/PD） models of incretin related agents can be useful tools in optimal drug therapy in patients and support the design of future clinical trials.Meanwhile , a mechanism-based model can be more powerful at predic-ting physiological characteritics and the probability of successful outcome of anti -diabetic treatment for different dosage regimens of the drugs , which will be beneficial for new drugs development and dosage regimens regulation.The present review is focused on the mechanism -based PK/PD models of representative drugs which belong to GLP -1 receptor agonists and DPP-4 inhibitors.
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2015年第2期146-149,共4页
The Chinese Journal of Clinical Pharmacology
